Table 2.
The hazard ratio and its 95 % CI and associated p-value for selected predictors derived from a Cox proportional hazards regression models for each of the three outcomes of interest. Each of the regression models control for all the covariates listed in the Methods section.
| Predictor | HR (95 % CI) | p-Value | HR (95 % CI) | p-Value | HR (95 % CI) | p-Value | HR (95 % CI) | p-Value |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|||||
| Time to AMI, stroke or death | Time to AMI | Time to stroke | Time to death | |||||
|
| ||||||||
| AF | 1.10 (1.08, 1.13) | <0.0001 | 1.10 (1.05, 1.15) | <0.0001 | 1.31 (1.22, 1.39) | <0.0001 | 1.09 (1.06, 1.12) | <0.0001 |
| Male | 1.13 (1.11, 1.14) | <0.0001 | 1.12 (1.09, 1.15) | <0.0001 | 0.85 (0.82, 0.89) | <0.0001 | 1.15 (1.13, 1.17) | <0.0001 |
| Black race (Ref = white) | 1.01 (0.99, 1.04) | 0.3747 | 1.02 (0.97, 1.06) | 0.4718 | 1.43 (1.34, 1.52) | <0.0001 | 0.99 (0.97, 1.02) | 0.4371 |
| Hispanic race (Ref = white) | 0.91 (0.88, 0.94) | <0.0001 | 0.96 (0.91, 1.01) | 0.1434 | 1.19 (1.09, 1.29) | <0.0001 | 0.87 (0.84, 0.90) | <0.0001 |
| Other/unknown race (Ref = white) | 0.90 (0.87, 0.94) | <0.0001 | 0.98 (0.92, 1.05) | 0.5677 | 1.18 (1.06, 1.32) | 0.0031 | 0.87 (0.83, 0.91) | <0.0001 |
| Age 71 to 75 (baseline = 66 to 70) | 1.11 (1.08, 1.13) | <0.0001 | 1.06 (1.02, 1.10) | 0.0035 | 1.11 (1.04, 1.19) | 0.0030 | 1.15 (1.12, 1.18) | <0.0001 |
| Age 76 to 80 (baseline = 66 to 70) | 1.26 (1.23, 1.29) | <0.0001 | 1.09 (1.05, 1.13) | <0.0001 | 1.22 (1.14, 1.30) | <0.0001 | 1.38 (1.34, 1.41) | <0.0001 |
| Age 81 to 85 (baseline = 66 to 70) | 1.48 (1.44, 1.51) | <0.0001 | 1.19 (1.14, 1.24) | <0.0001 | 1.36 (1.28, 1.46) | <0.0001 | 1.67 (1.62, 1.71) | <0.0001 |
| Age over 85 (baseline = 66 to 70) | 1.90 (1.85, 1.94) | <0.0001 | 1.41 (1.35, 1.47) | <0.0001 | 1.47 (1.37, 1.58) | <0.0001 | 2.25 (2.19, 2.31) | <0.0001 |
| Baseline comorbidities | ||||||||
| Hypertension | 0.95 (0.92, 0.98) | 0.0036 | 0.98 (0.93, 1.04) | 0.5708 | 1.13 (1.04, 1.24) | 0.0060 | 0.91 (0.88, 0.95) | <0.0001 |
| Diabetes mellitus | 0.98 (0.96, 1.01) | 0.1321 | 1.06 (1.01, 1.10) | 0.0109 | 0.98 (0.92, 1.05) | 0.6109 | 0.96 (0.93, 0.98) | <0.0001 |
| Chronic kidney disease | 1.10 (1.08, 1.12) | <0.0001 | 1.15 (1.10, 1.19) | <0.0001 | 1.03 (0.97, 1.10) | 0.3436 | 1.10 (1.08, 1.13) | <0.0001 |
| Stroke | 1.09 (1.06, 1.11) | <0.0001 | 0.86 (0.82, 0.91) | <0.0001 | 1.58 (1.48, 1.68) | <0.0001 | 1.11 (1.08, 1.14) | <0.0001 |
| Heart failure | 1.27 (1.25, 1.29) | <0.0001 | 1.27 (1.24, 1.31) | <0.0001 | 1.10 (1.05, 1.15) | 0.0001 | 1.33 (1.31, 1.36) | <0.0001 |
| Depression | 1.03 (1.00, 1.05) | 0.0357 | 0.96 (0.91, 1.00) | 0.0550 | 0.97 (0.90, 1.05) | 0.4446 | 1.05 (1.02, 1.08) | 0.0004 |
| Overweight/obese | 0.89 (0.86, 0.91) | <0.0001 | 0.92 (0.88, 0.96) | 0.0004 | 0.90 (0.83, 0.97) | 0.0064 | 0.86 (0.84, 0.89) | <0.0001 |
| Sleep apnea | 0.93 (0.90, 0.96) | <0.0001 | 0.93 (0.88, 0.99) | 0.0219 | 1.00 (0.90, 1.10) | 0.9505 | 0.92 (0.89, 0.96) | <0.0001 |
| Stent placementa | 1.34 (1.30, 1.38) | <0.0001 | 1.60 (1.52, 1.38) | <0.0001 | 1.11(1.03, 1.20) | 0.0095 | 1.30 (1.26, 1.35) | <0.0001 |
| CABGa | 0.56 (0.55, 0.58) | <0.0001 | 0.49 (0.47, 0.52) | <0.0001 | 0.77 (0.71, 0.82) | <0.0001 | 0.55 (0.53, 0.57) | <0.0001 |
| Medications | ||||||||
| Beta blockers | 1.00 (0.98, 1.01) | 0.6085 | 1.09 (1.06, 1.12) | <0.0001 | 1.08 (1.03, 1.12) | 0.0008 | 0.96 (0.95, 0.98) | <0.0001 |
| ACE inhibitors | 0.98 (0.97, 1.00) | 0.0132 | 1.03 (1.00, 1.05) | 0.0453 | 0.99 (0.95, 1.04) | 0.7697 | 0.97 (0.95, 0.98) | <0.0001 |
| ARB | 0.91 (0.89, 0.92) | <0.0001 | 0.97 (0.94, 1.00) | 0.0830 | 1.02 (0.97, 1.07) | 0.5560 | 0.88 (0.86, 0.89) | <0.0001 |
| Clopidogrel | 1.06 (1.05, 1.08) | <0.0001 | 1.19 (1.16, 1.23) | <0.0001 | 1.17 (1.11, 1.23) | <0.0001 | 1.03 (1.01, 1.05) | 0.0029 |
| Warfarinb | 0.84 (0.82, 0.85) | <0.0001 | 0.90 (0.86, 0.93) | <0.0001 | 1.07 (1.00, 1.14) | 0.0409 | 0.79 (0.77, 0.81) | <0.0001 |
Procedure during index admission.
Present 90 days after index; HR, hazard ratio; CI, confidence interval; ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker.